Callan JMB Announces Arrival of Rapid Dose Therapeutics’ QuickStrip™, Resulting in $15 Million in Projected Revenue Over the Next 18 months
Key Highlights
- ➤Callan JMB (CJMB) received RDT’s complete QuickStrip oral thin-film production line
- ➤QuickStrip platform projected to generate up to $15 million in revenue over 18 months
- ➤Equipment installation will launch U.S.-based oral thin-film manufacturing operations
- ➤Revenue projection depends on successful equipment qualification and remains forward-looking
- ➤Callan JMB says project requires no additional capital raise
Expert Statements
Wayne Williams, Chief Executive Officer of Callan JMB
“This shipment is an important milestone in our vision to fast track the building of a comprehensive U.S.-based pharmaceutical manufacturing and healthcare logistics platform”
Wayne Williams, Chief Executive Officer of Callan JMB
“We continue to implement capabilities that will help us reach our goal of strengthen healthcare supply chain resiliency, support domestic manufacturing, and create long-term value for our customers and shareholders.”
Wayne Williams, Chief Executive Officer of Callan JMB
“We believe oral thin-film delivery technology represents one of the most promising segments of pharmaceutical innovation today.”
Wayne Williams, Chief Executive Officer of Callan JMB
“Today’s positive announcement demonstrates our commitment to a rapid roll out of these advancements.”
Wayne Williams, Chief Executive Officer of Callan JMB
“This new opportunity aligns directly with our strategy of leveraging our existing infrastructure and healthcare logistics capabilities to create scalable, recurring revenue streams while supporting domestic pharmaceutical manufacturing. Neither the completion of this project nor the recently announced IV Bag manufacturing facility require us to raise any additional capital.”
Milestone advances Callan JMB’s domestic pharmaceutical manufacturing strategy and is expected to create a new high-margin healthcare manufacturing revenue stream at their Texas facility.
SPRING BRANCH, Texas, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Callan JMB, Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), a diversified healthcare logistics, preparedness, and critical infrastructure company, today announced that it has received a complete QuickStrip(™) oral thin-film production line from Rapid Dose Therapeutics Corp. (“RDT”) for installation at the Company’s facility in Texas.
Get started
Create a free account to read the full story.